NCT06927648View on ClinicalTrials.gov

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Not yet recruitingOBSERVATIONAL

Enrollment

130

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

February 28, 2030

Study Completion Date

February 28, 2030

Conditions

Breast Cancer

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY